Come up with a name for your new list and we'll add to it:
Tragara Pharmaceuticals raised a round of funding on March 15, 2010. Investors include
Multiple Myeloma Research Foundation.
Tragara Pharmaceuticals is a pharmaceutical company focused on the clinical and commercial development of drugs for the treatment of various cancers. TG02 is an orally available, small molecule that t…